Report cover image

Global Substance Abuse Treatment Market

Publisher Coherent Market Insights
Published Jul 17, 2025
Length 180 Pages
SKU # CMI20303024

Description

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study
  • This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global substance abuse treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.
Market Segmentation
  • Global Substance Abuse Treatment Market, By Type
  • Alcohol
  • Opioids (e.g., heroin, prescription painkillers)
  • Tobacco/nicotine
  • Cocaine
  • Marijuana
  • Methamphetamines
  • Other illicit drugs (Benzodiazepines, etc.)
  • Global Substance Abuse Treatment Market, By Treatment Type
  • Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
  • Global Substance Abuse Treatment Market, By Age Group
  • Adolescents
  • Adults
  • Geriatric
  • Global Substance Abuse Treatment Market, By Treatment Setting
  • Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
  • Detoxification Centers
  • Global Substance Abuse Treatment Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Top Companies
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd.
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

Table of Contents

180 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Treatment Type
Market Snippet, By Age Group
Market Snippet, By Treatment Setting
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers:
Increasing consumption of drugs and alcohol
Growing support from government and NGOs
Restraints
Social stigma associated with substance dependence
Lack of adequate rehabilitation facilities
Opportunities
Untapped markets in developing countries
Company Market Share Analysis
Key Highlights
Market Trends
PEST Analysis
PORTER’s Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations
4. Global Substance Abuse Treatment Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Alcohol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Opioids (e.g., heroin, prescription painkillers)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Tobacco/nicotine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Cocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Marijuana
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Methamphetamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Other illicit drugs (Benzodiazepines, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
5. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Opioid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Methadone
Buprenorphine
Extended-release naltrexone
Lofexidine
Nicotine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Nicotine replacement therapies (available as a patch, inhaler, or gum)
Bupropion
Varenicline
Alcohol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Naltrexone
Disulfiram
Acamprosate
Tobacco
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Clonidine
Nortriptyline
Others (Topiramate, Modafinil, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
6. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Adolescents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
7. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Outpatient Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Outpatient Clinics
Private Practices
Inpatient Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Rehabilitation Centers
Hospitals
Residential Treatment Facilities
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Detoxification Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
8. Global Substance Abuse Treatment Market, By Region, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2020 – 2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profile
Indivior PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mallinckrodt Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Teva Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Par Pharmaceutical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
USWM, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Valeant Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Greenyard Pharmaceutical Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cipla Health Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Perrigo
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Haleon Group of Companies
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ventus Medical
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Glenmark
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Other Prominent Players
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
References
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us